FDA approves 2 new protease inhibitors: ritonavir (Norvir) and Crixivan (Indinavir sulfate). Food and Drug Administration.
Schouten
J T
JT
D017277:Drug Approval; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy / Q000821:virology; D017320:HIV Protease Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D019469:Indinavir; D011725:Pyridines / Q000008:administration & dosage / Q000627:therapeutic use*; D019438:Ritonavir; D013844:Thiazoles / Q000008:administration & dosage / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration; D014633:Valine / Q000008:administration & dosage / Q000627:therapeutic use*
D017320:HIV Protease Inhibitors; D011725:Pyridines; D013844:Thiazoles; D019469:Indinavir; D014633:Valine; D019438:Ritonavir